Entity Details

Primary name CO1A2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP08123
EntryNameCO1A2_HUMAN
FullNameCollagen alpha-2(I) chain
TaxID9606
Evidenceevidence at protein level
Length1366
SequenceStatuscomplete
DateCreated1988-08-01
DateModified2021-06-02

Ontological Relatives

GenesCOL1A2

GO terms

Show/Hide Table
GOName
GO:0001501 skeletal system development
GO:0001568 blood vessel development
GO:0002020 protease binding
GO:0005201 extracellular matrix structural constituent
GO:0005576 extracellular region
GO:0005584 collagen type I trimer
GO:0005615 extracellular space
GO:0005783 endoplasmic reticulum
GO:0005788 endoplasmic reticulum lumen
GO:0007179 transforming growth factor beta receptor signaling pathway
GO:0007266 Rho protein signal transduction
GO:0007596 blood coagulation
GO:0008217 regulation of blood pressure
GO:0019221 cytokine-mediated signaling pathway
GO:0030020 extracellular matrix structural constituent conferring tensile strength
GO:0030168 platelet activation
GO:0030198 extracellular matrix organization
GO:0030199 collagen fibril organization
GO:0030282 bone mineralization
GO:0030674 protein-macromolecule adaptor activity
GO:0031012 extracellular matrix
GO:0032963 collagen metabolic process
GO:0042476 odontogenesis
GO:0042802 identical protein binding
GO:0043589 skin morphogenesis
GO:0046332 SMAD binding
GO:0046872 metal ion binding
GO:0048407 platelet-derived growth factor binding
GO:0050776 regulation of immune response
GO:0050900 leukocyte migration
GO:0062023 collagen-containing extracellular matrix
GO:0070062 extracellular exosome
GO:0070208 protein heterotrimerization
GO:0071230 cellular response to amino acid stimulus
GO:0085029 extracellular matrix assembly

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR000885 Fibrillar collagen, C-terminalDomainDomain
IPR008160 Collagen triple helix repeatRepeatRepeat

Diseases

Show/Hide Table
Disease IDSourceNameDescription
166210 OMIMOsteogenesis imperfecta 2 (OI2)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. The disease is caused by variants affecting the gene represented in this entry.
225320 OMIMEhlers-Danlos syndrome, cardiac valvular type (EDSCV)A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSCV is an autosomal recessive disease characterized by mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency, in addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation. The disease is caused by variants affecting the gene represented in this entry.
617821 OMIMEhlers-Danlos syndrome, arthrochalasia type, 2 (EDSARTH2)A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSARTH2 is an autosomal dominant condition characterized by frequent congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement. The disease is caused by variants affecting the gene represented in this entry.
166220 OMIMOsteogenesis imperfecta 4 (OI4)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. The disease is caused by variants affecting the gene represented in this entry.
166200 OMIMOsteogenesis imperfecta 1 (OI1)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. The disease is caused by variants affecting the gene represented in this entry.
259420 OMIMOsteogenesis imperfecta 3 (OI3)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. The disease is caused by variants affecting the gene represented in this entry.

Interactions

39 interactions

InteractorPartnerSourcesPublicationsLink
CO1A2_HUMANITA2_HUMANHPRD, MINT17485091 2156854 details
CO1A2_HUMANZNF16_HUMANUniProt21874239 details
CO1A2_HUMANLYOX_HUMANmatrixdb21690299 details
CO1A2_HUMANAP2A_HUMANIntAct24835590 details
CO1A2_HUMANAP2C_HUMANIntAct24835590 details
CO1A2_HUMANCO5A1_HUMANmatrixdb20979576 details
CO1A2_HUMANSGTA_HUMANBioGRID, IntAct25416956 26871637 32296183 details
CO1A2_HUMANUBQL1_HUMANBioGRID, IntAct25416956 26871637 32296183 details
CO1A2_HUMANKCIP4_HUMANBioGRID, IntAct26871637 32296183 details
CO1A2_HUMANSGTB_HUMANBioGRID, IntAct26871637 details
CO1A2_HUMANUBQL2_HUMANBioGRID, IntAct30442662 32296183 details
CO1A2_HUMANEIF3F_HUMANBioGRID, IntAct32296183 details
CO1A2_HUMANMESD_HUMANBioGRID, IntAct32296183 details
CO1A2_HUMANSMRD1_HUMANBioGRID, IntAct32296183 details
CO1A2_HUMANSHBG_HUMANBioGRID, HPRD15862967 details
CO1A2_HUMANMYOC_HUMANBioGRID, HPRD16289162 details
CO1A2_HUMANDNLI4_HUMANBioGRID22990118 details
CO1A2_HUMANPDGFA_HUMANBioGRID8900172 details
CO1A2_HUMANPDGFB_HUMANBioGRID8900172 details
CO1A2_HUMANSPB5_HUMANBioGRID11788595 details
CO1A2_HUMANDISC1_HUMANIntAct31413325 details
CO1A2_HUMANCO1A1_HUMANBioGRID, matrixdb18375391 24981860 26848503 details
CO1A2_HUMANHIS3_HUMANBioGRID26544073 details
CO1A2_HUMANCO5A3_HUMANHPRD10722718 6501291 7346227 details
CO1A2_HUMANMMP9_HUMANHPRD9878537 details
CO1A2_HUMANC1QR1_HUMANHPRD1377218 details
CO1A2_HUMANPGS2_HUMANHPRD1468447 2375748 9675033 details
CO1A2_HUMANFINC_HUMANHPRD8468356 details
CO1A2_HUMANITB3_HUMANHPRD1693626 details
CO1A2_HUMANCD36_HUMANHPRD10772928 details
CO1A2_HUMANSPRC_HUMANHPRD7034958 details
CO1A2_HUMANVWF_HUMANHPRD3490481 details
CO1A2_HUMANPGS1_HUMANHPRD7852349 details
CO1A2_HUMANLUM_HUMANHPRD10734230 details
CO1A2_HUMANBGH3_HUMANHPRD11867580 12034705 details
CO1A2_HUMANITA2B_HUMANHPRD11359786 details
CO1A2_HUMANPDIA1_HUMANHPRD10329688 details
CO1A2_HUMANA4_HUMANHPRD7688497 details
CO1A2_HUMANCD44_HUMANHPRD1730778 details